Applied DNA Sciences prices $12M public offering of units with warrants subject to stockholder approval

BNB PLUS CORP.

Gross proceeds of ~$12M from 9,230,769 units at $1.30 per unit (or $1.2999 with pre-funded warrant).
Each unit includes one share (or pre-funded warrant) plus two Series A and B warrants exercisable at $1.99 after stockholder approval.
Proceeds to fund therapeutic DNA production services, MDx testing, and general corporate purposes.
Offering closed May 29, 2024; Craig-Hallum and Laidlaw & Co. acted as placement agents.
Warrants are not exercisable until stockholder approval obtained; special meeting planned within 90 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.